Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
| Author | |
|---|---|
| Abstract | :
Heme oxygenase (HO) catalyzes NADPH-dependent degradation of heme to liberate iron, carbon monoxide and biliverdin. The interaction between HO and cytochrome P450 reductase (CPR), an electron donor, is essential for HO activity. HO-1 is a stress-inducible isoform whereas HO-2 is constitutively expressed. HO-1 induction is commonly seen in cancers and impacts disease progression, supporting the possibility of targeting HO-1 for cancer therapy. |
| Year of Publication | :
2018
|
| Journal | :
Journal of biomedical science
|
| Volume | :
25
|
| Issue | :
1
|
| Number of Pages | :
6
|
| Date Published | :
2018
|
| ISSN Number | :
1021-7770
|
| URL | :
https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-018-0411-y
|
| DOI | :
10.1186/s12929-018-0411-y
|
| Short Title | :
J Biomed Sci
|
| Download citation |